Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2014, Article ID 804654, 9 pages
http://dx.doi.org/10.1155/2014/804654
Research Article

Impact of Serum Biomarkers and Clinical Factors on Intensive Care Unit Mortality and 6-Month Outcome in Relatively Healthy Patients with Severe Pneumonia and Acute Respiratory Distress Syndrome

1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan
2Department of Respiratory Care, Chang Gung University of Science and Technology, Chiayi 813, Taiwan
3Department of Respiratory Therapy, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan

Received 30 December 2013; Accepted 29 January 2014; Published 3 March 2014

Academic Editor: Vincent Sapin

Copyright © 2014 Chia-Cheng Tseng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Sharma, B. Maycher, and G. Eschun, “Radiological imaging in pneumonia: recent innovations,” Current Opinion in Pulmonary Medicine, vol. 13, no. 3, pp. 159–169, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Roupie, E. Lepage, M. Wysocki et al., “Prevalence, etiologies and outcome of the acute respiratory distress syndrome among hypoxemic ventilated patients,” Intensive Care Medicine, vol. 25, no. 9, pp. 920–929, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Brun-Buisson, C. Minelli, G. Bertolini et al., “Epidemiology and outcome of acute lung injury in European intensive care units: results from the ALIVE study,” Intensive Care Medicine, vol. 30, no. 1, pp. 51–61, 2004. View at Publisher · View at Google Scholar
  4. N. Petrucci and W. Iacovelli, “Ventilation with lower tidal volumes versus traditional tidal volumes in adults for acute lung injury and acute respiratory distress syndrome,” Cochrane Database of Systematic Reviews, no. 3, Article ID CD003844, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. R. G. Brower, M. A. Matthay, A. Morris, D. Schoenfeld, B. T. Thompson, and A. Wheeler, “Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome,” The New England Journal of Medicine, vol. 342, no. 18, pp. 1301–1308, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. J. A. Milberg, D. R. Davis, K. P. Steinberg, and L. D. Hudson, “Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983–1993,” Journal of the American Medical Association, vol. 273, no. 4, pp. 306–309, 1995. View at Google Scholar · View at Scopus
  7. P. Markowicz, M. Wolff, K. Djedaïni et al., “Multicenter prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome: incidence, prognosis, and risk factors,” American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 6, pp. 1942–1948, 2000. View at Google Scholar · View at Scopus
  8. R. O. Hopkins and M. S. Herridge, “Quality of life, emotional abnormalities, and cognitive dysfunction in survivors of acute lung injury/acute respiratory distress syndrome,” Clinics in Chest Medicine, vol. 27, no. 4, pp. 679–689, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. D. M. Needham, C. R. Dennison, D. W. Dowdy et al., “Study protocol: the Improving Care of Acute Lung Injury Patients (ICAP) study,” Critical Care, vol. 10, no. 1, article R9, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. C. M. Lee and L. D. Hudson, “Long-term outcomes after ARDS,” Seminars in Respiratory and Critical Care Medicine, vol. 22, no. 3, pp. 327–336, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. T. A. Davidson, G. D. Rubenfeld, E. S. Caldwell, L. D. Hudson, and K. P. Steinberg, “The effect of acute respiratory distress syndrome on long-term survival,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 6, pp. 1838–1842, 1999. View at Google Scholar · View at Scopus
  12. M. E. Wilcox and M. S. Herridge, “Long-term outcomes in patients surviving acute respiratory distress syndrome,” Seminars in Respiratory and Critical Care Medicine, vol. 31, no. 1, pp. 55–65, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. M. S. Herridge, C. M. Tansey, A. Matté et al., “Functional disability 5 years after acute respiratory distress syndrome,” The New England Journal of Medicine, vol. 364, no. 14, pp. 1293–1304, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. H. W. H. van Hees, W.-J. M.-J. Schellekens, M. Linkels et al., “Plasma from septic shock patients induces loss of muscle protein,” Critical Care, vol. 15, article R233, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. J. S. Garner, W. R. Jarvis, T. G. Emori, T. C. Horan, and J. M. Hughes, “CDC Defionitions for nosocomial infections, 1988,” American Journal of Infection Control, vol. 16, no. 3, pp. 128–140, 1988. View at Google Scholar · View at Scopus
  16. “Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia,” American Journal of Respiratory and Critical Care Medicine, vol. 171, no. 4, pp. 388–416, 2005. View at Publisher · View at Google Scholar
  17. G. R. Bernard, A. Artigas, K. L. Brigham et al., “The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination,” American Journal of Respiratory and Critical Care Medicine, vol. 149, no. 3, pp. 818–824, 1994. View at Google Scholar · View at Scopus
  18. P. G. Davey and C. Marwick, “Appropriate vs. inappropriate antimicrobial therapy,” Clinical Microbiology and Infection, vol. 14, supplement 3, pp. 15–21, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Collin, D. T. Wade, S. Davies, and V. Horne, “The Barthel ADL Index: a reliability study,” International Disability Studies, vol. 10, no. 2, pp. 61–63, 1988. View at Google Scholar · View at Scopus
  20. S. Christensen, M. B. Johansen, C. F. Christiansen, R. Jensen, and S. Lemeshow, “Comparison of Charlson comorbidity index with SAPS and APACHE scores for prediction of mortality following intensive care,” Clinical Epidemiology, vol. 3, no. 1, pp. 203–211, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Pittet, B. Thievent, R. P. Wenzel, N. Li, G. Gurman, and P. M. Suter, “Importance of pre-existing co-morbidities for prognosis of septicemia in critically ill patients,” Intensive Care Medicine, vol. 19, no. 5, pp. 265–272, 1993. View at Google Scholar · View at Scopus
  22. J. A. Johnston, D. P. Wagner, S. Timmons, D. Welsh, J. Tsevat, and M. L. Render, “Impact of different measures of comorbid disease on predicted mortality of intensive care unit patients,” Medical Care, vol. 40, no. 10, pp. 929–940, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. K. M. Ho, M. Knuiman, J. Finn, and S. A. Webb, “Estimating long-term survival of critically ill patients: the PREDICT model,” PLoS ONE, vol. 3, no. 9, Article ID e3226, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. M. E. Charlson, P. Pompei, K. A. Ales, and C. R. MacKenzie, “A new method of classifying prognostic comorbidity in longitudinal studies: development and validation,” Journal of Chronic Diseases, vol. 40, no. 5, pp. 373–383, 1987. View at Google Scholar · View at Scopus
  25. D. M. Needham, D. C. Scales, A. Laupacis, and P. J. Pronovost, “A systematic review of the Charlson comorbidity index using Canadian administrative databases: a perspective on risk adjustment in critical care research,” Journal of Critical Care, vol. 20, no. 1, pp. 12–19, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. R. A. Deyo, D. C. Cherkin, and M. A. Ciol, “Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases,” Journal of Clinical Epidemiology, vol. 45, no. 6, pp. 613–619, 1992. View at Publisher · View at Google Scholar · View at Scopus
  27. M. S. Niederman, “Use of broad-spectrum antimicrobials for the treatment of pneumonia in seriously ill patients: maximizing clinical outcomes and minimizing selection of resistant organisms,” Clinical Infectious Diseases, vol. 42, supplement 2, pp. S72–S81, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Pea and P. Viale, “The antimicrobial therapy puzzle: could pharmacokinetic-pharmacodynamic relationships be helpful in addressing the issue of appropriate pneumonia treatment in critically ill patients?” Clinical Infectious Diseases, vol. 42, no. 12, pp. 1764–1771, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Pea and P. Viale, “Bench-to-bedside review: appropriate antibiotic therapy in severe sepsis and septic shock—does the dose matter?” Critical Care, vol. 13, no. 3, article 214, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Wang, O. Bloom, M. Zhang et al., “HMG-1 as a late mediator of endotoxin lethality in mice,” Science, vol. 285, no. 5425, pp. 248–251, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. E. Abraham, J. Arcaroli, A. Carmody, H. Wang, and K. J. Tracey, “Cutting edge: HMG-1 as a mediator of acute lung inflammation,” Journal of Immunology, vol. 165, no. 6, pp. 2950–2954, 2000. View at Google Scholar · View at Scopus
  32. E. N. Ogawa, A. Ishizaka, S. Tasaka et al., “Contribution of high-mobility group box-1 to the development of ventilator-induced lung injury,” American Journal of Respiratory and Critical Care Medicine, vol. 174, no. 4, pp. 400–407, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. V. S. Patel, R. A. Sitapara, A. Gore et al., “High Mobility Group Box-1 mediates hyperoxia-induced impairment of Pseudomonas aeruginosa clearance and inflammatory lung injury in mice,” American Journal of Respiratory Cell and Molecular Biology, vol. 48, no. 3, pp. 280–287, 2013. View at Publisher · View at Google Scholar
  34. S. Karlsson, V. Pettilä, J. Tenhunen, R. Laru-Sompa, M. Hynninen, and E. Ruokonen, “HMGB1 as a predictor of organ dysfunction and outcome in patients with severe sepsis,” Intensive Care Medicine, vol. 34, no. 6, pp. 1046–1053, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Parkkinen, E. Raulo, J. Merenmies et al., “Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation,” Journal of Biological Chemistry, vol. 268, no. 26, pp. 19726–19738, 1993. View at Google Scholar · View at Scopus
  36. J. R. Klune, R. Dhupar, J. Cardinal, T. R. Billiar, and A. Tsung, “HMGB1: endogenous danger signaling,” Molecular Medicine, vol. 14, no. 7-8, pp. 476–484, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Visser, S. B. Kritchevsky, A. B. Newman et al., “Lower serum albumin concentration and change in muscle mass: the Health, Aging and Body Composition study,” American Journal of Clinical Nutrition, vol. 82, no. 3, pp. 531–537, 2005. View at Google Scholar · View at Scopus
  38. A. Loban, R. Kime, and H. Powers, “Iron-binding antioxidant potential of plasma albumin,” Clinical Science, vol. 93, no. 5, pp. 445–451, 1997. View at Google Scholar · View at Scopus
  39. A. M. Cantin, B. Paquette, M. Richter, and P. Larivée, “Albumin-mediated regulation of cellular glutathione and nuclear factor kappa B activation,” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 4, pp. 1539–1546, 2000. View at Google Scholar · View at Scopus
  40. O. Pansarasa, L. Castagna, B. Colombi, J. Vecchiet, G. Felzani, and F. Marzatico, “Age and sex differences in human skeletal muscle: role of reactive oxygen species,” Free Radical Research, vol. 33, no. 3, pp. 287–293, 2000. View at Google Scholar · View at Scopus